Attached files
| file | filename |
|---|---|
| EX-5.1 - MARRONE BIO INNOVATIONS INC | ex5-1.htm |
| S-1 - MARRONE BIO INNOVATIONS INC | forms-1.htm |
EXHIBIT 23.1
Independent Registered Public Accounting Firm’s Consent
We consent to the incorporated by reference in this Registration Statement of Marrone Bio Innovations, Inc. on Form S-1 of our report which includes an explanatory paragraph as to the Company’s ability to continue as a going concern, dated March 16, 2020, with respect to our audits of the consolidated financial statements of Marrone Bio Innovations, Inc. as of December 31, 2019 and 2018 and for each of the two years in the period ended December 31, 2019 and our report dated March 16, 2020 with respect to our audit of the effectiveness of internal control over financial reporting of Marrone Bio Innovations, Inc. as of December 31, 2019 appearing in the Annual Report on Form 10-K of Marrone Bio Innovations, Inc. for the year ended December 31, 2019 filed with the Securities and Exchange Commission. We also consent to the reference to our firm under the heading “Experts” in such Prospectus.
Our report on the consolidated financial statements refers to a change in the method of accounting for leases in 2019 due to the adoption of Accounting Standards Update No. 2016-12, Leases (Topic 842), as amended, effective January 1 2019, using the modified retrospective approach.
| /s/ Marcum llp |
Marcum llp
San Francisco, CA
March 20, 2020